Last reviewed · How we verify

NCT05944497

Changes in Pulse Wave Transit Time and Its Variability After Placement of Interscalene Brachial Plexus Block

Completed Last updated 23 January 2024
What this trial tests

trial testing Interscalene brachial plexus block in Interscalene Brachial Plexus Block in 59 participants. Completed in 7 January 2024.

Timeline
31 July 2023
Primary endpoint
7 January 2024
7 January 2024

Quick facts

Lead sponsorJongHae Kim
StatusCompleted
Study typeOBSERVATIONAL
Enrollment59
Start date31 July 2023
Primary completion7 January 2024
Estimated completion7 January 2024
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

JongHae Kim — full company profile →

Who can join

Adults 20 to 60, any sex, with Interscalene Brachial Plexus Block. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pulse wave transit time (PWTT) increases due to decreased arterial vascular tone resulting from sympathetic blockade caused by regional anesthesia. Its oscillation (PWTT variability) also contains information on the interaction between autonomic nervous system and the cardiovascular system. The changes in PWTT and its variability have not been investigated in patients receiving interscalene brachial plexus block (ISBPB). It was hypothesized that ISBPB increases PWTT and reduces low frequency power of PWTT variability.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Changes in pulse wave transit time variability after interscalene brachial plexus block placement.
    Choi EJ, Lim JA, Choi CH, Kim DH, et al · · 2026 · PMID 40398868 · DOI 10.4097/kja.24861

Verify or expand the search:

Other trials of Interscalene brachial plexus block

Trials testing the same drug.

Other recruiting trials for Interscalene Brachial Plexus Block

Currently open trials in the same condition.

Other JongHae Kim trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05944497.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing